Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02375113 · ClinicalTrials.gov registry record · NA
Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women
A NA study of Central Obesity, sponsored by The University of Texas at San Antonio.
- Completed
- Registry status
- NA
- Development phase
- 12
- Enrollment target
- 1
- Study location
NCT02375113: Completed NA study of Central Obesity, sponsored by The University of Texas at San Antonio.
NCT02375113 is a NA study of Central Obesity that has completed, run by The University of Texas at San Antonio. The registered enrollment target is 12 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02375113, a NA study of Central Obesity, has completed, sponsored by The University of Texas at San Antonio.
- COMPLETED
- Registry status
- NA
- Development phase
- 12 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study examining the effect of dietary supplements that contain soy products. The purpose of this study to find out if soy supplementation can help to reduce the storage of a certain kind of fat on the body, visceral fat. Visceral fat is fat found deep in the abdomen; it has the potential to increase the risk of certain health problems.
Primary Outcome
Total body fat and abdominal fat were measured by DEXA (Hologic QDR Discovery A, Bedford, MA)
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT soy supplementation
Study Locations (1)
Texas
- Human Nutrition Lab, UTSA - San Antonio
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-12 |
| Phase | NA |
What the finished NCT02375113 record still lists
NCT02375113 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Central Obesity appearing as the primary indexed condition, and to 1 intervention - of which soy supplementation is the first listed.
NCT02375113 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02375113 about?
NCT02375113 is a clinical study titled "Soy as an Innovative Dietary Component in Abdominal Obesity Management Amongst Peri- and Early Menopausal Women". This is a pilot study examining the effect of dietary supplements that contain soy products. The purpose of this study to find out if soy supplementation can help to reduce the storage of a certain kind of fat on the body, visceral fat. Visceral fat is fat found deep in the abdomen; it has the poten...
What is the current status of trial NCT02375113?
This trial is currently completed. It is a NA study. The enrollment target is 12 participants. The study started on 2012-09. Estimated completion is 2014-12.
What conditions does trial NCT02375113 study?
This clinical trial studies the following conditions: Central Obesity.
What interventions are being tested in trial NCT02375113?
The interventions under investigation include: soy supplementation (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02375113?
This trial is sponsored by The University of Texas at San Antonio, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02375113 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Obesity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02375113's enrollment target sits among peer trials
12 1913th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia